Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Palmitate causes endoplasmic reticulum stress and apoptosis in human mesenchymal stem cells: prevention by AMPK activator.

Authors
  • Lu, Jun
  • Wang, Qinghua
  • Huang, Lianghu
  • Dong, Huiyue
  • Lin, Lingjing
  • Lin, Na
  • Zheng, Feng
  • Tan, Jianming
Type
Published Article
Journal
Endocrinology
Publisher
The Endocrine Society
Publication Date
Nov 01, 2012
Volume
153
Issue
11
Pages
5275–5284
Identifiers
DOI: 10.1210/en.2012-1418
PMID: 22968644
Source
Medline
License
Unknown

Abstract

Elevated circulating saturated fatty acids concentration is commonly associated with poorly controlled diabetes. The highly prevalent free fatty acid palmitate could induce apoptosis in various cell types, but little is known about its effects on human mesenchymal stem cells (MSCs). Here, we report that prolonged exposure to palmitate induces human bone marrow-derived MSC (hBM-MSC) and human umbilical cord-derived MSC apoptosis. We investigated the role of endoplasmic reticulum (ER) stress, which is known to promote cell apoptosis. Palmitate activated XBP1 splicing, elF2α (eukaryotic translation initiation factor 2α) phosphorylation, and CHOP, ATF4, BiP, and GRP94 transcription in hBM-MSCs. ERK1/2 and p38 MAPK phosphorylation were also induced by palmitate in hBM-MSCs. A selective p38 inhibitor inhibited palmitate activation of the ER stress, whereas the ERK1/2 inhibitors had no effect. The AMP-activated protein kinase activator aminoimidazole carboxamide ribonucleotide blocked palmitate-induced ER stress and apoptosis. These findings suggest that palmitate induces ER stress and ERK1/2 and p38 activation in hBM-MSCs, and AMP-activated protein kinase activator prevents the deleterious effects of palmitate by inhibiting ER stress and apoptosis.

Report this publication

Statistics

Seen <100 times